Eventide Gilead Class I ETILX

Eventide Gilead remains a decent option for investors, particularly those with an interest in faith-based investments. This strategy combines environmental, social, and governance factors and faith-based criteria with traditional fundamental analysis to identify high-quality companies trading at a discount to intrinsic value. Positive and negative screens guide the process: the team excludes businesses involved in activities such as abortion, alcohol, and weaponry while actively seeking out companies deemed to have a beneficial impact on the environment and broader society. These exclusions meaningfully narrow the investable universe to a more concentrated set of stocks aligned with Eventide's values, and likely screen out opportunities that would interest other investors. The firm’s emphasis on healthcare further drives substantial differences relative to the Russell Midcap Growth Index. The result is a portfolio of 65 to 70 holdings which often looks quite different from the typical mid-cap growth peer.